Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00858494
Other study ID # 35537
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2009
Est. completion date October 2009

Study information

Verified date July 2018
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if a commercially available homeopathic cold remedy for children is effective in providing relief from cold symptoms in children 2-5 years old. It is postulated that children will have relief of symptoms after receiving a dose of the cold remedy


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 2009
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender All
Age group 24 Months to 59 Months
Eligibility Inclusion Criteria:

- Children 24-59 months old

- Cold/cough symptoms of <7 days duration

- Diagnosed with upper respiratory tract infection by physician or nurse practitioner

- Parent who speaks and reads English

Exclusion Criteria:

- Use of chronic medication other than multivitamins

- History of asthma

- Medication other than acetaminophen or ibuprofen

- Use of homeopathic remedy within preceding 30 days

- Only 1 participant per family

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hyland's Cold 'n Cough 4 Kids
Liquid homeopathic cold remedy, 5 ml by mouth every 4 hours as needed for relief of cold symptoms for up to 10 days

Locations

Country Name City State
United States University of Washington Medical Center-Roosevelt Pediatric Care Center Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
University of Washington Standard Homeopathic Company

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy. For each dose of study medication, parents indicated which of the symptoms were present (runny nose, cough, nasal congestion, sneezing). Parents rated change in each symptom present one hour after a dose of study medication for up to 6 doses in study logs. Responses were dichotomized as at least some improvement or better (improvement) vs. no improvement or worse. The outcome measure is number of times that improvement in a specific symptom was noted after a dose of the homeopathic remedy. Completed study logs were received from 37 of 49 enrolled participants. up to 10 days from index visit
Secondary Parental Report of an Adverse Event After a Dose of Study Medication After each dose of study medication parents reported the presence of any adverse events data collected after doses occurring up to 10 days after index visit
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06052540 - Probiotic Supplementation in Children Affected by Upper Respiratory Infections N/A
Completed NCT04960878 - The Effect of Synbiotics on the Upper Respiratory Tract Infection N/A
Terminated NCT00979667 - A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection Phase 3
Recruiting NCT04479657 - Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection Early Phase 1
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting NCT06065176 - The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection Phase 4
Recruiting NCT01985620 - The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. N/A
Completed NCT01875757 - Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life Phase 3
Recruiting NCT00551382 - Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study Phase 3
Completed NCT00393835 - A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis Phase 3
Completed NCT06149117 - Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China Phase 4
Not yet recruiting NCT05612893 - Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
Active, not recruiting NCT05569330 - Effect of Aerosol Filtering on Infectious Diseases in Day Care N/A
Recruiting NCT05374070 - Antiviral Activity of Oral Probiotics N/A
Completed NCT00707941 - Oseltamivir Randomised Controlled Efficacy Trial Phase 3
Completed NCT04955327 - To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI Phase 3
Completed NCT01735084 - Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Phase 4
Not yet recruiting NCT03461692 - A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China N/A
Completed NCT03011515 - Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
Recruiting NCT05915390 - Walnut and Immunity Study N/A